Canterbury Scientific
Canterbury Scientific, founded in 1985 and based in Christchurch, New Zealand, specializes in the development and supply of high-quality in vitro diagnostic (IVD) controls and calibrators. The company operates as an original equipment manufacturer (OEM), focusing on providing essential products that support accurate diagnostic testing in the healthcare sector. With a commitment to quality and innovation, Canterbury Scientific plays a significant role in enhancing the reliability of diagnostic processes.
Top Stages
2 past transactions
Aptatek Biosciences
Seed Round in 2024
Aptatek Biosciences Inc specializes in the development of portable medical devices for the management of Phenylketonuria (PKU), a genetic disorder that affects metabolism. Based in Princeton, New Jersey, the company utilizes advanced sensor technology to provide real-time monitoring of phenylalanine levels in patients. Its innovative devices enable users to conduct blood tests on-the-go, facilitating immediate dietary adjustments to maintain phenylalanine levels within clinical target ranges. By leveraging DNA aptamer sequences, Aptatek can detect a variety of small-molecule biomarkers and other health indicators, enhancing the diagnosis and management of PKU and other inborn diseases. This technology aims to improve patient compliance and overall quality of life while streamlining the traditional laboratory analysis process.
Aptatek Biosciences
Seed Round in 2022
Aptatek Biosciences Inc specializes in the development of portable medical devices for the management of Phenylketonuria (PKU), a genetic disorder that affects metabolism. Based in Princeton, New Jersey, the company utilizes advanced sensor technology to provide real-time monitoring of phenylalanine levels in patients. Its innovative devices enable users to conduct blood tests on-the-go, facilitating immediate dietary adjustments to maintain phenylalanine levels within clinical target ranges. By leveraging DNA aptamer sequences, Aptatek can detect a variety of small-molecule biomarkers and other health indicators, enhancing the diagnosis and management of PKU and other inborn diseases. This technology aims to improve patient compliance and overall quality of life while streamlining the traditional laboratory analysis process.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.